Colleagues,
Several of you have noted last Friday's announcement that Thomson Scientific
has acquired Current Drugs Ltd, and have asked me how that move affects
Current Patents Ltd. In fact, along with PharmaPress Ltd, Current Patents
forms part of the deal, and we are expecting that there will be only
positive implications for DOLPHIN and our other products. The press release
is located at:
http://www.newswire.ca/releases/August2002/23/c5107.html
Regards
Peter Steele
Current Patents
Middlesex House, 34-42 Cleveland Street
London W1T 4LB, UK
Tel: +44 20 7323 0323, Direct: 7631 9194, Fax: 7631 9927
E-mail: peter.steele@current-patents.com
http://www.current-patents.com
DOLPHIN, the Database of all Pharmaceutical Inventions
http://www.cp-dolphin.com
----------------------------------------------------------------------------------------------------------------------
The information contained in this email is confidential and intended
only for the use of the individual or entity named above. If the reader
of this message is not the intended recipient, you are hereby notified
that any dissemination, distribution, or copying of this communication
is strictly prohibited. Derwent Information Limited will accept no responsibility
or liability in respect to this email other than to the addressee. If you
have received this communication in error, please notify us
immediately via email: postmaster@derwent.co.uk
----------------------------------------------------------------------------------------------------------------------
This archive was generated by hypermail 2b30 : Fri Feb 14 2003 - 11:57:01 GMT